Wet granulation of tenofovir, emtricitabine and efavirenz

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 31/675 (2006.01)

Patent

CA 2744211

The present invention describes a method and composition for a pharmaceutical product based on Tenofovir disoproxil hemifumarate, Emtricitabine and Efavirenz. The composition can be prepared by a process comprising a wet granulation step to produce a stable dosage form suitable for the treatment of HIV in essential absence of known degradation products.

La présente invention concerne une méthode et une composition de produit pharmaceutique basées sur le diisopropoxylhémifumarate de Tenofovir, lEmtricitabine et lEfavirenz. La composition peut être élaborée suivante un procédé comprenant une étape de granulation humide pour reproduire une forme galénique stable adaptée au traitement du VIH essentiellement en l'absence de produits de dégradation connus.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Wet granulation of tenofovir, emtricitabine and efavirenz does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Wet granulation of tenofovir, emtricitabine and efavirenz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wet granulation of tenofovir, emtricitabine and efavirenz will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1451722

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.